PI3K

CAT # Inoa Huahana wehewehe
CPD1573 GDC-0077 ʻO GDC-0077 kahi mea hoʻopaneʻe PI3K i loaʻa i ka waha me ka hana antineoplastic.
CPD1022 IPI-549 ʻO IPI549 kahi mea hoʻoweliweli PI3Kγ ikaika a koho me kahi IC50 o 16 nM.
CPDD3857 GDC-0326 ʻO GDC-0326 kahi mea hoʻopaneʻe ikaika a koho i ka α-Isoform o Phosphoinositide 3-Kinase (PI3Kalpha inhibitor). Loaʻa iā GDC-0326 kahi kiʻekiʻe kiʻekiʻe o ka koho ma luna o nā kinases ʻē aʻe. Loaʻa iā GDC-0326 ka plasma CL haʻahaʻa i ke kanaka.
CPDB0202 AZD8186 ʻO AZD8186 a me ka mea hoʻopaneʻe o ka beta isoform o phosphoinositide-3 kinase (PI3K), me ka hana antineoplastic.
CPDB1536 PQR530 ʻO PQR530 kahi mea hoʻopaneʻe pan-PI3K/mTORC1/2 ikaika loa.
CPDB1573 GDC-0077 ʻO GDC-0077 kahi mea hoʻopaneʻe PI3K i loaʻa i ka waha a koho ʻia (IC50 = 0.038 + 0.003 nM) me ka koho koho 300-fold ma luna o nā isoforms Class I PI3K.
,

Kāhea iā mā˚ou

Ninau

Nuhou Hou

  • ʻO 7 ʻoi loa ma ka noiʻi lāʻau lapaʻau ma 2018

    ʻO 7 ʻoi loa i ka noiʻi lāʻau lapaʻau I...

    Ma lalo o ka piʻi nui ʻana o ka hoʻokūkū e hoʻokūkū i kahi ʻenehana paʻakikī a me ka ʻenehana, pono e hoʻomau nā ʻoihana lāʻau lapaʻau a me biotech i kā lākou papahana R&D e noho i mua ...

  • ARS-1620: He mea hoʻohiki hou no nā maʻi maʻi KRAS-mutant

    ARS-1620: He mea hoʻohiki hou no K...

    Wahi a kahi noiʻi i paʻi ʻia ma Cell, ua hoʻomohala nā mea noiʻi i kahi inhibitor kūikawā no KRASG12C i kapa ʻia ʻo ARS-1602 i hoʻoulu i ka regression tumor i nā ʻiole. "Ke hāʻawi nei kēia haʻawina i nā hōʻike vivo e hiki ke lilo i mutant KRAS ...

  • Loaʻa iā AstraZeneca ka hoʻoikaika kānāwai no nā lāʻau lapaʻau oncology

    Loaʻa iā AstraZeneca ka hoʻonui hoʻoponopono no...

    Ua loaʻa iā AstraZeneca kahi hoʻonui pālua no kāna kōpili oncology i ka Pōʻalua, ma hope o ka ʻae ʻana o nā regulators US a me ʻEulopa i nā hoʻouna kānāwai no kāna mau lāʻau lapaʻau, ʻo ka hana mua i ka lanakila ʻana i kēia mau lāʻau lapaʻau. ...

WhatsApp Online Chat !